A PYMNTS Company

Ireland: Medtronic shifts medical device operations with $43B purchase

By  |  June 16, 2014

US-based Medtronic has reportedly inked a deal with Ireland-based Covidien, a move that will lead to Medtronic to move its medical device manufacturing operations overseas.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Reports say Medtronic will acquire Covidien for $42.9 billion and move its executive base to Ireland. It’s part of a strategy by the US firm to reduce its tax burden, which will allow the company to allocate more funds for US investment, the company said.

    The merger will also establish a greater competitor to current medical device behemoth Johnson & Johnson. The acquisition of Covidien will expand Medtronic’s medical device portfolio into weight-loss surgery and other services, according to reports.

    The deal remains subject to regulatory approval.

    In related news, the European Commission recently announced plans to investigate three member states, including Ireland, and their tax relationships with major companies including Starbucks and Apple.

    Full content: Irish Times

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.